Huang-tz J. Ou

Tainan, TNQ, Taiwan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 89 publications

Depression following the initiation of glucagon-like-peptide-1 receptor agonist therapy: A multinational self-controlled case series study.

Depression following the initiation of glucagon-like-peptide-1 receptor agonist therapy: A multinational self-controlled case series study.

Journal: Journal of internal medicine

Published: April 16, 2026

Correction: Cost Effectiveness of Exclusionary EGFR Testing for Taiwanese Patients Newly Diagnosed with Advanced Lung Adenocarcinoma.

Correction: Cost Effectiveness of Exclusionary EGFR Testing for Taiwanese Patients Newly Diagnosed with Advanced Lung Adenocarcinoma.

Journal: PharmacoEconomics

Published: December 17, 2025

Kidney Effectiveness and Safety of Adding Spironolactone in Patients With Type 2 Diabetes Receiving Renin-Angiotensin System Inhibitors Therapy.

Kidney Effectiveness and Safety of Adding Spironolactone in Patients With Type 2 Diabetes Receiving Renin-Angiotensin System Inhibitors Therapy.

Journal: Clinical and translational science

Published: September 21, 2025

A comparative analysis of biologics market dynamics in 12 countries: (Bio)similar and sustainability.

A comparative analysis of biologics market dynamics in 12 countries: (Bio)similar and sustainability.

Journal: Frontiers in pharmacology

Published: July 04, 2025

Different dosage protocols of atosiban in repeated implantation failure before embryo transfer: A double-blind randomized controlled trial.

Different dosage protocols of atosiban in repeated implantation failure before embryo transfer: A double-blind randomized controlled trial.

Journal: Taiwanese journal of obstetrics & gynecology

Published: May 28, 2025

Comparative effectiveness and prescribing patterns of dapagliflozin vs empagliflozin in type 2 diabetes patients: a target trial emulation.

Comparative effectiveness and prescribing patterns of dapagliflozin vs empagliflozin in type 2 diabetes patients: a target trial emulation.

Journal: Diabetes research and clinical practice

Published: May 05, 2025

Economic burdens of type 1 diabetes and its complications: A nationwide, longitudinal analysis.

Economic burdens of type 1 diabetes and its complications: A nationwide, longitudinal analysis.

Journal: Diabetes research and clinical practice

Published: April 16, 2025

Cost-effectiveness of ON101 with general wound care for diabetic foot ulcers among patients with type 2 diabetes in Singapore: Analysis of a multi-ethnic country in Asia.

Cost-effectiveness of ON101 with general wound care for diabetic foot ulcers among patients with type 2 diabetes in Singapore: Analysis of a multi-ethnic country in Asia.

Journal: Diabetes, obesity & metabolism

Published: March 19, 2025

Efficient estimation of the cox model when incorporating the subgroup restricted mean survival time.

Efficient estimation of the cox model when incorporating the subgroup restricted mean survival time.

Journal: Journal of biopharmaceutical statistics

Published: March 13, 2025

Visit-to-visit lipid variability and adverse kidney events in real-world type 2 diabetes patients.

Visit-to-visit lipid variability and adverse kidney events in real-world type 2 diabetes patients.

Journal: Diabetes research and clinical practice

Published: January 15, 2025

Clinical effectiveness and cost-effectiveness of first-line early combination of dipeptidyl peptidase 4 inhibitors and metformin in patients with type 2 diabetes in Taiwan: A modelling study.

Clinical effectiveness and cost-effectiveness of first-line early combination of dipeptidyl peptidase 4 inhibitors and metformin in patients with type 2 diabetes in Taiwan: A modelling study.

Journal: Diabetes, obesity & metabolism

Published: December 03, 2024

Cost Effectiveness of Exclusionary EGFR Testing for Taiwanese Patients Newly Diagnosed with Advanced Lung Adenocarcinoma.

Cost Effectiveness of Exclusionary EGFR Testing for Taiwanese Patients Newly Diagnosed with Advanced Lung Adenocarcinoma.

Journal: PharmacoEconomics

Published: December 01, 2024

Showing 1-12 of 89

Last Updated: 09/26/2026